EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment
出版年份 2017 全文链接
标题
EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 6, Pages 1295
出版商
MDPI AG
发表日期
2017-06-19
DOI
10.3390/ijms18061295
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Glioblastoma vaccine therapy disappointment in Phase III trial
- (2016) Hemi Malkki Nature Reviews Neurology
- EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation
- (2016) Eskil Eskilsson et al. NEURO-ONCOLOGY
- A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients
- (2015) J. J. Raizer et al. JOURNAL OF NEURO-ONCOLOGY
- A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
- (2015) J. Schuster et al. NEURO-ONCOLOGY
- Notching on Cancer’s Door: Notch Signaling in Brain Tumors
- (2015) Marcin Teodorczyk et al. Frontiers in Oncology
- Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
- (2015) Emily Padfield et al. Frontiers in Oncology
- Quantitative Proteomic Analysis Reveals Effects of Epidermal Growth Factor Receptor (EGFR) on Invasion-promoting Proteins Secreted by Glioblastoma Cells
- (2014) Vineet Sangar et al. MOLECULAR & CELLULAR PROTEOMICS
- JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma
- (2014) Q. Zheng et al. NEURO-ONCOLOGY
- Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
- (2014) P. Y. Wen et al. NEURO-ONCOLOGY
- MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma
- (2014) Fei Wang et al. TUMOR BIOLOGY
- EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis
- (2013) Krishna M. Talasila et al. ACTA NEUROPATHOLOGICA
- EGFL7 ligates v 3 integrin to enhance vessel formation
- (2013) I. Nikolic et al. BLOOD
- EGFR Phosphorylates Tumor-Derived EGFRvIII Driving STAT3/5 and Progression in Glioblastoma
- (2013) Qi-Wen Fan et al. CANCER CELL
- Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion
- (2013) Deborah Huveldt et al. PLoS One
- Blockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27KIP1 and MMP3 expression
- (2012) Xun Jin et al. CANCER LETTERS
- Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance
- (2012) T. E. Taylor et al. CURRENT CANCER DRUG TARGETS
- The regulation of cysteine cathepsins and cystatins in human gliomas
- (2012) Boris Gole et al. INTERNATIONAL JOURNAL OF CANCER
- Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis
- (2012) H. Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma
- (2012) D Kesanakurti et al. Cell Death & Disease
- Heterogeneity Maintenance in Glioblastoma: A Social Network
- (2011) R. Bonavia et al. CANCER RESEARCH
- Epidermal growth factor induces matrix metalloproteinase-1 (MMP-1) expression and invasion in glioma cell lines via the MAPK pathway
- (2011) M. Anand et al. JOURNAL OF NEURO-ONCOLOGY
- Mechanism of p27 upregulation induced by downregulation of cathepsin B and uPAR in glioma
- (2011) Sreelatha Gopinath et al. Molecular Oncology
- EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
- (2011) R Bonavia et al. ONCOGENE
- Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells
- (2011) J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The effect of epidermal growth factor receptor variant III on glioma cell migration by stimulating ERK phosphorylation through the focal adhesion kinase signaling pathway
- (2010) Mingzhu Liu et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells
- (2010) Xiao Yue et al. BRAIN RESEARCH
- Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of β-catenin-mediated transcription
- (2010) Lei Han et al. BRAIN RESEARCH
- Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
- (2010) S. A. Grossman et al. CLINICAL CANCER RESEARCH
- Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma
- (2010) M.-d.-M. Inda et al. GENES & DEVELOPMENT
- Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin
- (2010) Melarkode S. Ramakrishnan et al. mAbs
- Understanding resistance to EGFR inhibitors—impact on future treatment strategies
- (2010) Deric L. Wheeler et al. Nature Reviews Clinical Oncology
- Fyn and Src Are Effectors of Oncogenic Epidermal Growth Factor Receptor Signaling in Glioblastoma Patients
- (2009) K. V. Lu et al. CANCER RESEARCH
- Integrins
- (2009) Malgorzata Barczyk et al. CELL AND TISSUE RESEARCH
- Molecular Mechanisms Underlying Effects of Epidermal Growth Factor Receptor Inhibition on Invasion, Proliferation, and Angiogenesis in Experimental Glioma
- (2009) J.-S. Guillamo et al. CLINICAL CANCER RESEARCH
- EGF-Induced ERK Activation Promotes CK2-Mediated Disassociation of α-Catenin from β-Catenin and Transactivation of β-Catenin
- (2009) Haitao Ji et al. MOLECULAR CELL
- Src kinases as therapeutic targets for cancer
- (2009) Lori C. Kim et al. Nature Reviews Clinical Oncology
- Oncogenic EGFR Signaling Networks in Glioma
- (2009) P. H. Huang et al. Science Signaling
- Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth
- (2008) P Pu et al. CANCER GENE THERAPY
- Notch-1 regulates transcription of the epidermal growth factor receptor through p53
- (2008) Benjamin W. Purow et al. CARCINOGENESIS
- Trafficking of receptor tyrosine kinases to the nucleus
- (2008) Graham Carpenter et al. EXPERIMENTAL CELL RESEARCH
- Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway
- (2008) N. de la Iglesia et al. GENES & DEVELOPMENT
- Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
- (2008) Jinyan Du et al. NATURE BIOTECHNOLOGY
- The function of Stat3 in tumor cells and their microenvironment
- (2008) Bernd Groner et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCδ, and sphingosine kinase 1 in glioblastoma cells
- (2007) Barbara S. Paugh et al. FASEB JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started